SEEL logo

Seelos Therapeutics (SEEL) Company Overview

Profile

Full Name:

Seelos Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 19, 1999

Indexes:

Not included

Description:

Seelos Therapeutics is a biopharmaceutical company focused on developing innovative treatments for central nervous system disorders. They aim to address unmet medical needs through advanced therapies, particularly for conditions like depression and Parkinson's disease, using a science-driven approach to improve patient outcomes.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 21, 2024

Recent annual earnings:

Mar 7, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 27, 2024

Analyst ratings

Recent major analysts updates

Sep 22, 23 Guggenheim
Neutral
Sep 21, 23 Guggenheim
Neutral
Sep 21, 23 Cantor Fitzgerald
Neutral
Sep 21, 23 Benchmark
Speculative Buy
Aug 22, 23 Cantor Fitzgerald
Overweight
Aug 15, 23 Cantor Fitzgerald
Overweight
Jun 23, 23 Cantor Fitzgerald
Overweight
Jun 23, 23 Benchmark
Speculative Buy
Jun 13, 23 BTIG
Buy
May 16, 23 Cantor Fitzgerald
Overweight

Screeners with SEEL included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Similar stocks

FAQ

  • What is the ticker symbol for Seelos Therapeutics?
  • Does Seelos Therapeutics pay dividends?
  • What sector is Seelos Therapeutics in?
  • What industry is Seelos Therapeutics in?
  • What country is Seelos Therapeutics based in?
  • When did Seelos Therapeutics go public?
  • Is Seelos Therapeutics in the S&P 500?
  • Is Seelos Therapeutics in the NASDAQ 100?
  • Is Seelos Therapeutics in the Dow Jones?
  • When was Seelos Therapeutics's last earnings report?
  • When does Seelos Therapeutics report earnings?
  • Should I buy Seelos Therapeutics stock now?

What is the ticker symbol for Seelos Therapeutics?

The ticker symbol for Seelos Therapeutics is NASDAQ:SEEL

Does Seelos Therapeutics pay dividends?

No, Seelos Therapeutics does not pay dividends

What sector is Seelos Therapeutics in?

Seelos Therapeutics is in the Healthcare sector

What industry is Seelos Therapeutics in?

Seelos Therapeutics is in the Biotechnology industry

What country is Seelos Therapeutics based in?

Seelos Therapeutics is headquartered in United States

When did Seelos Therapeutics go public?

Seelos Therapeutics's initial public offering (IPO) was on April 19, 1999

Is Seelos Therapeutics in the S&P 500?

No, Seelos Therapeutics is not included in the S&P 500 index

Is Seelos Therapeutics in the NASDAQ 100?

No, Seelos Therapeutics is not included in the NASDAQ 100 index

Is Seelos Therapeutics in the Dow Jones?

No, Seelos Therapeutics is not included in the Dow Jones index

When was Seelos Therapeutics's last earnings report?

Seelos Therapeutics's most recent earnings report was on Nov 21, 2024

When does Seelos Therapeutics report earnings?

The date for Seelos Therapeutics's next earnings report has not been announced yet

Should I buy Seelos Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions